About the Authors
- Emuella Flood
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
* E-mail: emuella.flood@astrazeneca.com
Affiliation AstraZeneca plc, Patient-Centered Science, Gaithersburg, Maryland, United States of America
- Anna Krasnow
-
Roles Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing
Affiliation IQVIA Real World Solutions, Patient-Centered Solutions, London, United Kingdom
- Cecilia Orbegoso
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom
- Stella Karantzoulis
-
Roles Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America
- Julie Bailey
-
Roles Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing
Affiliation IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America
- Solène Bayet
-
Roles Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing
Affiliation IQVIA Real World Solutions, Patient-Centered Solutions, Courbevoie, France
- Arthur Elghouayel
-
Roles Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America
- Andrew Foxley
-
Roles Supervision, Writing – review & editing
Affiliation AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom
- Roberto Sommavilla
-
Roles Conceptualization, Writing – review & editing
Affiliation AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom
- Gaia Schiavon
-
Roles Conceptualization, Methodology, Supervision, Writing – review & editing
Affiliation AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom
Competing Interests
EF, AF, and GS are employees of AstraZeneca and AstraZeneca shareholders; RS is an employee of AstraZeneca and has AstraZeneca stock options; AK, SK, JB, SB, and AE received consultancy fees from AstraZeneca (paid to IQVIA). This does not alter our adherence to PLOS ONE policies on sharing data and materials.